PTK2 and gastric cancer: Therefore, in assessing the anti-cancer effects of TSPAN9 and the downstream mechanism, this study found that TSPAN9 disrupts gastric cancer cell invasion and migration by inhibiting the FAK-RAS-ERK1/2 pathway by over-expressing and knocking down TSPAN9 in gastric cancer cells in vitro.